Milestone Scientific Inc. Q1 2026 Earnings Call Summary

Milestone Scientific (MLSS) reported a 30% year-over-year reduction in operating expenses and flat revenue for Q1 2026, primarily due to unshipped orders caused by regional conflict. Medical segment revenue more than doubled driven by the CompuFlo system adoption.

By Moby Intelligence Fri, May 15, 2026 at 12:21 AM GMT+3 3 min read · Yahoo Finance · May 14, 2026, 21:21 UTC

Milestone Scientific Inc. Q1 2026 Earnings Call Summary

Tickers: $MLSS $NVDA

Topics: earnings medical technology adoption operational performance

Read the full article at Yahoo Finance

More World news

Lucid Diagnostics Reports Q3 2026 Results Amid Transition to Medicare Reimbursement Motley Fool · November 12, 2026, 15:39 UTC
National Vision Reports Q3 2026 Revenue Growth Driven by Higher Average Ticket Motley Fool · November 12, 2026, 15:40 UTC
Okeanis Eco Tankers Reports Record Q3 2026 Results Driven by High Freight Rates Motley Fool · November 12, 2026, 15:41 UTC
Nvidia Shares Plunge Following Resignation of CEO Jensen Huang Motley Fool · November 12, 2026, 15:35 UTC
Jensen Huang Resigns as Nvidia CEO; Colette Kress Appointed Interim CEO TechCrunch · November 12, 2026, 15:37 UTC
Merck KGaA Raises 2026 Outlook Amid Pending Bio-Techne Acquisition Seeking Alpha · November 12, 2026, 15:31 UTC
Chinese AI Firms Seek Alternative Access to Nvidia Chips Amid Potential US Export Restrictions Seeking Alpha · November 12, 2026, 15:32 UTC
Purcell & Lefkowitz LLP Launches Shareholder Investigation into Dick's Sporting Goods PR Newswire · November 12, 2026, 15:34 UTC
Pomerantz Law Firm Investigates Fervo Energy Following Allegations of Securities Fraud PR Newswire · November 12, 2026, 15:35 UTC
Pomerantz Law Firm Investigates Boston Scientific Following Q3 Earnings Miss and Guidance Downgrade PR Newswire · November 12, 2026, 15:35 UTC